Breakout Stocks of Week 19 @ GER
NASDAQ was up last week (week 18) by 1.43% ending at 16,156.33 points after gaining 228.43 points during the week. Our system has detected some possible breakout stocks for the following week and these should be on your watchlist. These are the stocks that are bouncing up with good increase in volume and are likely to do good in short term. One of these stocks are Covestro AG GER:1COV. This stock has had a buy signal since May 02, 2024 when the price was 47.22€ and is so far up 0.424% to 47.42€. Some other companies are on our watchlist to, among these are Bayerische Motoren Werke Aktiengesellschaft GER:BMW3 Volkswagen AG GER:VOW3 Hannover Rück SE GER:HNR1 and Linde plc GER:LIN which all got a breakout pattern emerging.
| Date | Company | Price | Week 19 |
|---|---|---|---|
| Covestro Ag | 47.42€ | 48.21€ | 1.67% |
| Bayerische Motoren Werke Aktiengesellschaft | 97.00€ | 96.60€ | -0.412% |
| Volkswagen Ag | 115.50€ | 116.95€ | 1.26% |
| Hannover Rück Se | 229.40€ | 237.30€ | 3.44% |
| Linde Plc | 392.20€ | 403.00€ | 2.75% |
The Covestro AG stock price gained 0.424% on the last trading day (Friday, 3rd May 2024), rising from 47.22€ to 47.42€. During the last trading day the stock fluctuated 1.21% from a day low at 47.18€ to a day high of 47.75€. The price has fallen in 5 of the last 10 days and is down by -5.07% for this period. Volume fell on the last day by -119 thousand shares and in total, 584 thousand shares were bought and sold for approximately 27.71€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Covestro AG:
Covestro AG supplies high-tech polymer materials and related application solutions. It operates in two segments, Performance Materials, and Solutions & Specialties. The Performance Materials segment develops, produces, and supplies high-performance materials, such as polyurethanes and polycarbonates, and base chemicals, which include diphenylmethane diisocyanate (MDI), toluylene diisocyanate, long-chain polyols, and polycarbonate resins for use in furniture and wood processing, construction, automotive, and transportation industries, as well as roof structures, insulation for buildings and refrigerators, mattresses, car seats, and other applications. The Solutions & Specialties segment comprises a range of polymer products, including precursors for coatings and adhesives, polycarbonates, MDI specialties and polyols, specialty films, elastomers, and thermoplastic polyurethanes that are used in automotive and transportation, electrical, electronics and household appliances, construction, and healthcare industries, as well as composite resins for wind turbine, rotor blades, laptop cases, and floodlights. The company markets its products through trading houses and distributors. It operates in Europe, the Middle East, Africa, Latin America, the United States, Canada, and the People's Republic of China. The company was founded in 1863 and is headquartered in Leverkusen, Germany.
The Bayerische Motoren Werke stock price gained 0.518% on the last trading day (Friday, 3rd May 2024), rising from 96.50€ to 97.00€. During the last trading day the stock fluctuated 1.24% from a day low at 96.50€ to a day high of 97.70€. The price has risen in 6 of the last 10 days but is still down by -2.27% for this period. Volume fell on the last day by -17 thousand shares and in total, 68 thousand shares were bought and sold for approximately 6.64€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Bayerische Motoren Werke Aktiengesellschaft:
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
The Volkswagen AG stock price gained 1.01% on the last trading day (Friday, 3rd May 2024), rising from 114.35€ to 115.50€. During the last trading day the stock fluctuated 2.05% from a day low at 114.85€ to a day high of 117.20€. The price has been going up and down for this period, and there has been a -5.29% loss for the last 2 weeks. Volume fell on the last day by -364 thousand shares and in total, 874 thousand shares were bought and sold for approximately 100.89€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period.
About Volkswagen AG:
Volkswagen, abbreviated as VW, is a German motor vehicle manufacturer headquartered in Wolfsburg, Lower Saxony, Germany.
The Hannover Rück SE stock price fell by -0.99% on the last day (Friday, 3rd May 2024) from 231.70€ to 229.40€. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.93% from a day low at 228.50€ to a day high of 232.90€. The price has been going up and down for this period, and there has been a -0.13% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -10 thousand shares and in total, 102 thousand shares were bought and sold for approximately 23.30€ million.
Hannover Rück SE holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Hannover Rück SE:
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
The Linde plc stock price gained 1.24% on the last trading day (Friday, 3rd May 2024), rising from 387.40€ to 392.20€. During the last trading day the stock fluctuated 1.61% from a day low at 386.20€ to a day high of 392.40€. The price has fallen in 7 of the last 10 days and is down by -6.84% for this period. Volume fell on the last day by -63 thousand shares and in total, 51 thousand shares were bought and sold for approximately 20.00€ million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
Linde plc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
About Linde plc:
Linde plc operates as an industrial gas and engineering company in North and South America, Europe, the Middle East, Africa, and the Asia Pacific. It offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene. The company also designs and constructs turnkey process plants for third-party customers, as well as for the gas businesses in various locations, such as olefin, natural gas, air separation, hydrogen, and synthesis gas plants. It serves a range of industries, including healthcare, energy, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, and water treatment. The company was founded in 1879 and is based in Woking, the United Kingdom.
Despite these candidates are looking good from a technical perspective they may not perform as expected. You should always be cautious when trading and base your decisions on more than one source of information. This does not constitute an offer or recommendation to buy or sell securities.
